German breast cancer DMP (disease management programme) backed by Schmidt:
This article was originally published in Clinica
Executive Summary
A new disease management programme (DMP) for the treatment of breast cancer in the German federal state of Baden-Wurrtemberg has received the tacit support of federal health minister Ulla Schmidt. The DMP, the result of an agreement between the Baden-Wurrtemberg hospitals' association, health insurance funds and doctors' association, focuses on offering treatment according to internationally accepted medical guidelines and standards. Ms Schmidt said that the opening of hospitals for outpatient treatment would play an important role in breast cancer care. The federal insurance department, which approves DMPs, has so far given the go-ahead for 186 programmes.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.